Reforming clinical research and development in England

British Medical Journal

Volumn 327, Issue 7414, 2003, Pages 550-553

  McNally, Nick ^a   Kerrison, Susan ^a   Pollock, Allyson M ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; CLINICAL RESEARCH; DEVELOPMENT; DRUG INDUSTRY; ETHICS; HEALTH CARE; HEALTH CARE NEED; LEGAL ASPECT; PATIENT; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM; ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; DEPARTMENT OF HEALTH (GREAT BRITAIN); ECONOMICS; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HEALTH SERVICES RESEARCH; HUMAN; MEDICAL RESEARCH; NATIONAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT;

BIOMEDICAL AND BEHAVIORAL RESEARCH; DEPARTMENT OF HEALTH (GREAT BRITAIN); NATIONAL HEALTH SERVICE;

BIOMEDICAL RESEARCH; FINANCING, GOVERNMENT; GREAT BRITAIN; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; RESEARCH SUPPORT; STATE MEDICINE;

EID: 0042471773     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.327.7414.550     Document Type: Review

References (23)

1. House of Lords Select Committee on Science and Technology. Priorities in medical research. Vol 1. London: HMSO, 1988.
2. Harrison A, New B. Public interest, private decisions: health-related research in the UK. London: King's Fund, 2002.
3. Department of Health. Research and development for a first class service. London: DoH, 2000. www.doh.gov.uk/research/documents/rd3/first_class_service.pdf (accessed 3 July 2003).
4. Department of Health website. www.doh.gov.uk/research/ (accessed 3 July 2003).
5. Culyer A. Supporting research and development in the NHS. Report of the Department of Health Research and Development Task Force. London: HMSO, 1994.
6. Arnold E, Morrow S, Thuriaux B, Martin B. Implementing the Culyer reforms in North Thames: final report, science and technology policy research. London: Technopolis, 1999.
7. Harrison A, New B. The finance of research and development in health care. Health Care UK 2001: the King's Fund review of health policy. London: King's Fund, 2001:26-44.
8. McCollum C. UK National Health Service R&D funding - a bureaucratic nightmare. Lancet 2003;361:1906.
9. Pharmaceutical Industry Competitiveness Taskforce. Final report. London: DoH, 2001.
10. Pharmaceutical Industry Competitiveness Taskforce. Clinical research report. London: DoH, 2002.
11. Department of Health. NHS Cancer Plan. London: DoH, 2000.
12. National Cancer Research Institute. Strategic analysis 2002. London: NCRI, 2002. http://www.ncri.org.uk/documents/publications/reportdocs/ NCRI_Strategic_Analysis_2002.pdf (accessed 2 July 2003).
13. National Cancer Tissue Resource. www.ntrac.org.uk/Inifiatives/NCTR/NCTR.asp (accessed 8 July 2003).
14. Office of Science and Technology. Public sector research exploitation fund - basic guidelines. www.ost.gov.uk/enterprise/knowledge/psrefundguide.pdf (accessed 5 August 2003).
15. Department of Health. Science and innovation strategy. London: DoH, 2001.
16. Department of Health. The NHS as an innovative organisation: a framework and guidance on the management of intellectual property in the NHS. London: DoH, 2002.
17. Department of Health. NHS R&D funding consultation paper: NHS support for science. London: DoH, 2000.
18. Department of Health. NHS R&D funding consultation paper: NHS priorities and needs funding. London: DoH, 2000.
19. Department of Health. NHS priorities and needs R&D funding: a position paper. London: DoH, 2001.
20. Kerrison S, McNally N, Pollock AM. United Kingdom research governance strategy. BMJ 2003;327:553-6.
21. Walt G, Brugha R, Haines A. Working with the private sector: the need for institutional guidelines. BMJ 2002;325:432-5.
22. Korn D. Conflicts of interest in biomedical research. JAMA 2000;284:2234-8.
23. Morin K, Rakatansky H, Riddick FA Jr, Morse LJ, O'Bannon JM 3rd, Goldrich MS, et al. Managing conflicts of interest in the conduct of clinical trials. JAMA 2002;287:78-84.